Delivery Order SPE2DB22D3016-SPE2DB26FABQ9
- Not listed
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $45,278.31 on July 28, 2025, by the Defense Logistics Agency's Medical Supply Chain with a completion date of July 29, 2025. This firm fixed price delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,514.52 on August 28, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price contract, with an ultimate completion date of August 29, 2025, represents a child order under the company's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999.999 billion through December 2026. The award...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $146,938.40 by the Defense Logistics Agency's Medical Supply Chain on November 5, 2025, with an ultimate completion date of November 6, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,304.88 by the Defense Logistics Agency's Medical Supply Chain on October 2, 2025. This firm fixed-price delivery order, with an ultimate completion date of October 3, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,604.01 on August 6, 2025, by the Defense Logistics Agency's Medical Supply Chain. The contract is a firm fixed-price delivery order with no set-aside designation and is scheduled for completion on August 7, 2025. This award represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $1,440 on September 18, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price contract, with an ultimate completion date of September 19, 2025, represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $164,276.30 on November 5, 2025, by the Defense Logistics Agency's Medical Supply Chain division. This firm fixed-price delivery order, which is set to be completed by November 6, 2025, represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated as SPE2DX, valued...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $5,112.32 on July 21, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of July 22, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical designated SPE2DX, valued at $999,999,999 and...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $35,279.84 on September 15, 2025, by the Defense Logistics Agency's Medical Supply Chain. This firm fixed-price delivery order, with an ultimate completion date of September 16, 2025, represents a child contract under AmerisourceBergen's broader Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00...
- AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a delivery order valued at $10,353.67 by the Defense Logistics Agency's Medical Supply Chain on October 6, 2025, with an ultimate completion date of October 7, 2025. This firm fixed-price delivery order, which is a non-set-aside award, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX) valued at...
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB26FABQ9Delivery Order
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, was awarded a $25,585.02 delivery order by the Defense Logistics Agency on November 7, 2025, for VYVGART 400 mg/20 ml vials. The contract represents a firm fixed price delivery order with an ultimate completion date of December 2, 2025, and was competitively awarded without set-aside designation. This award is a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX, which is valued at $999,999,999.00 and extends through December 2026. The delivery order supports the Defense Logistics Agency's medical supply chain operations, which serve military healthcare systems including the Defense Health Agency and U.S. Coast Guard. AmerisourceBergen's pharmaceutical portfolio under its DLA prime contract encompasses a comprehensive range of specialty medications, brand-name and generic drugs, and medical supplies across multiple therapeutic domains. The company's demonstrated capability to fulfill federal medical procurement requirements through open competition, combined with its strategic role as a pharmaceutical prime vendor, positions it to support critical military healthcare needs through flexible contract vehicles.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $25.6k | 11/7/25 |